Acute effect of hemodialysis on serum levels of the proinflammatory cytokines

Mediators of Inflammation

Volumn 12, Issue 1, 2003, Pages 15-19

  Tarakçioǧlu, Mehmet ^a   Erbaǧci, Ayşe Binnur ^a   Usalan, Celalettin ^a   Deveci, Rukiye ^a   Kocabaş, Ramazan ^a  

^a GAZIANTEP UNIVERSITY   (Turkey)

Author keywords

Clearance; Hemodialysis; Interleukin 8; Proinflammatory cytokines; Soluble interleukin 2 receptor

Indexed keywords

INTERLEUKIN 1BETA; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CHEMOLUMINESCENCE; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME IMMUNOASSAY; FEMALE; HEMODIALYSIS; HUMAN; KIDNEY CLEARANCE; KIDNEY FAILURE; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TREATMENT OUTCOME;

ADULT; BLOOD PROTEINS; CYTOKINES; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-1; INTERLEUKIN-6; INTERLEUKIN-8; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RECEPTORS, INTERLEUKIN-2; REGRESSION ANALYSIS; RENAL DIALYSIS; SERUM ALBUMIN; TUMOR NECROSIS FACTOR-ALPHA;

FISTULA;

EID: 0037657884     PISSN: 09629351     EISSN: None     Source Type: Journal    
DOI: 10.1080/0962935031000096935     Document Type: Article

References (26)

1. Stenvinkel P. The role of inflammation in the anaemia of end-stage renal disease. Nephrol Dial Transplant 2001; 16: 36-40.
2. Bolton CH, Downs LG, Victory JGG, et al. Endothelial dysfunction in chronic renal failure: roles of lipoprotein oxidation and pro-inflammatory cytokines. Nephrol Dial Transplant 2001; 16: 1188-1197.
3. Schiffl H, Lang SM, Stratakis D, Fischer R. Effects of ultrapure dialysis fluid on nutritional status and inflammatory parameters. Nephrol Dial Transplant 2001; 16: 1863-1869.
4. Zamauskaite A, Perez-Cruz I, Yaqoob MM, Madrigal JA, Cohen SBA. Effect of renal dialysis therapy modality on T cell cytokine production. Nephrol Dial Transplant 1999; 14: 49-55.
5. Sester U, Sester M, Hauk M, Kaul H, Köhler H, Girndt M. T-cell activation follows Th1 rather than Th2 pattern in haemodialysis patients. Nephrol Dial Transplant 2001; 15: 1217-1223.
6. Capelli G, DiFelice A, Perrone S, et al. Which level of cytokine production is critical in haemodialysis? Nephrol Dial Transplant 1998; 13: 55-60.
7. Kimmel PL, Phillips TM, Simmens SJ, et al. Immunologic function and survival in hemodialysis patients. Kidney Int 1998; 54: 236-244.
8. Yamasaki H, Nishi H, Nagake Y, Mino Y, Makino H. Changes in CD14 expression on monocytes and changes in serum soluble CD14 level during hemodialysis. Clin Exp Nephrol 2000; 4: 58-62.
9. Girndt M, Heisel O, Köhler H. Influence of dialysis with polyamide vs. haemophan haemodialysers on monokines and complement activation during a 4-month long-term study. Nephrol Dial Transplant 1999; 14: 676-682.
10. Gu Y, Ding F, Qin H, Zhao H, Lin S. Synergetic effect of dialyzer membrane and lipopolysaccharide on peripheral blood mononuclear cell cytokine production in uremic patients. Chin Med J 2000; 113: 315-319.
11. Fujimori A, Naito H, Miyazaki T. Adsorption of complement, cytokines, and proteins by different dialysis membrane materials: evaluation by a confocal laser scanning flourescence microscopy. Artif Organs 1998; 22: 1014-1017.
12. Lonnemann G, Koch KM, Shaldon S, Dinarello CA. Studies on the ability of hemodialysis membranes to induce, bind and clear human interleukin-1. J Lab Clin Med 1998; 112: 76-86.
13. Fischer K, Hamza A, Eisman R, Amoury M, Heynemann H, Fornora P. Differential diagnostic use of interleukin patterns in patients being monitored after transplantation. Clin Chim Acta 2001; 310: 71-80.
14. Xie K. Interleukin-8 and human cancer biology. Cytokine Growth Factor Rev 2001; 12: 375-391.
15. Hoffmann JN, Hartl WH, Faist E, Jochum M, Inthorn D. Tumor necrosis factor measurement and use of different anticoagulants: possible interference in plasma samples and supernatants from endotoxin-stimulated monocytes. Inflamm Res 1997; 46: 342-347.
16. Aukrust P, Berge RK, Ueland T, et al. Interaction between chemokines and oxidative stress: possible role in acute coronary syndromes. J Am Coll Cardiol 2001; 37: 485-491.
17. Tarakçioǧlu M, Erbaǧci AB, Çekmen M, et al. Acute effect of hemodialysis on serum markers of myocardial damage. Int J Clin Pract 2002; 56: 328-332.
18. Sander A, Armbruster W, Sander B, Daul AE, Lange R, Peters J. Hemofiltration increases IL-6 clearance in early systemic inflammatory response syndrome but does not alter IL-6 and TNFα plasma concentrations. Intensive Care Med 1997; 23: 878-884.
19. Herbelin A, Nguyen AT, Zingraff J, Urena P, Descamps-Latscha B. Influence of uremia and hemodialysis on circulating interleukin-1 and tumor necrosis factor alpha. Kidney Int 1990; 37: 116-125.
20. Massey HD, McPherson RA. Cytokines and adhesion molecules. In: Henry JB, ed. Clinical Diagnosis and Management by Laboratory Methods, Philadelphia: W.B. Saunders Co, 2001: 541-616.
21. Santos-Rosa M, Bienvenu J, Whitcher J. Cytokines. In: Burtis CA, Ashwood E, eds. Tietz Textbook of Clinical Chemistry, Philadelphia: W.B. Saunders Co, 1999: 914-926.
22. Gonzalez C, Cava F, Ayllón A, et al. Biological variation of interleukin-1β, interleukin-8, and tumor necrosis factor-α in serum of healthy individuals. Clin Chem Lab Med 2001; 39: 836-841.
23. Dugue B, Leppänen E. Short-term variability in the concentration of serum interleukin-6 and its soluble receptor in subjectively healthy persons. Clin Chem Lab Med 1998; 36: 323-325.
24. Hon WM, Lee JC, Lee KH. Effect of hemodialysis on plasma nitric oxide levels. Artif Organs 2000; 24: 387-390.
25. Heering P, Morgera S, Schmitz EJ, et al. Cytokine removal and cardiovascular hemodynamics in septic patients with continuous venovenous hemofiltration. Intensive Care Med 1997; 23: 288-296.
26. Millar AB, Armstrong L, van der Linden J, et al. Cytokine production and hemofiltration in children undergoing cardiopulmonary bypass. Ann Thorac Surg 1993; 56: 1499-1502.